Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
801people with dyslipidemia, in this paper
Already taking PCSK9 genetic variants, or nottheir own situation, not assigned
on PCSK9 genetic variants
not on carriers
PCSK9 genetic variants went with lower type 2 diabetes−1.19
correlation, not a testthe abstract, start to end
… predicted reduction in LDL-C was 1.19 (95% CI, 1.02-1.38; P = .03).
← favours treatmentfavours comparator →
could be chanceType 2 diabetesPCSK9 genetic variants vs non-carriers, in PCSK9
−1.19−1.38 to −1.02
PCSK9 inhibitorsLipids
1 / 4